Different reactivities of enzyme-linked immunosorbent assays for hepatocyte growth factor

被引:4
作者
Fukuta, Kazuhiro [1 ]
Adachi, Eri [1 ]
Matsumoto, Kunio [2 ]
Nakamura, Toshikazu [1 ]
机构
[1] Osaka Univ, Ctr Adv Sci & Innovat, Kringle Pharma Joint Res Div Regenerat Drug Disco, Suita, Osaka 5650871, Japan
[2] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa 9200934, Japan
关键词
HGF; ELISA; Reactivity; FACTOR/SCATTER FACTOR; HEPATECTOMIZED RATS; C-MET; LIVER; SERUM; PURIFICATION; EXPRESSION; INHIBITORS; CLEARANCE; RECEPTOR;
D O I
10.1016/j.cca.2008.12.011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Hepatocyte growth factor (HGF) plays diverse roles in organ development, tissue regeneration, and tumor progression. Measurement of HGF concentrations in blood and tissues using enzyme-linked immunosorbent assay (ELISA) is a simple and easy way to understand the significance of HGF in tissue regeneration, pathophysiology, and diagnosis. Methods: We evaluated 3 ELISA kits from different sources, referred to herein as kits A, B, and C for convenience. Results: We found that the concentrations of human HGF determined using ELISA vary significantly depending on the source of the ELISA kit. Kits A and B detected both single-chain pro-HGF and 2-chain mature HGF, but kit C detected only 2-chain HGF. A difference in reactivity was also detected during analysis of plasma samples. When rat plasma collected 4 h after subcutaneous administration of human HGF was analyzed, the HGF concentration determined using kit B was remarkably higher than those obtained using kits A and C. Results of a biological assay and Western blot analysis indicated that kit B detects even degraded HGF, by which the HGF concentrations determined using kit B were significantly overestimated. Conclusions: This information serves as a guide for the selection of ELISA kits for human HGF. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 26 条
[11]   IMPORTANCE OF THE LIVER IN PLASMA-CLEARANCE OF HEPATOCYTE GROWTH-FACTOR IN RATS [J].
LIU, KX ;
KATO, Y ;
NARUKAWA, M ;
KIM, DC ;
HANANO, M ;
HIGUCHI, O ;
NAKAMURA, T ;
SUGIYAMA, Y .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05) :G642-G649
[12]  
Matsumoto Kunio, 1992, Critical Reviews in Oncogenesis, V3, P27
[13]   Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions [J].
Matsumoto, Kunio ;
Nakamura, Toshikazu .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (03) :477-483
[14]   Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis [J].
Mizuno, Shinya ;
Nakamura, Toshikazu .
REGENERATIVE MEDICINE, 2007, 2 (02) :161-170
[15]   Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease [J].
Morishita, R ;
Aoki, M ;
Hashiya, N ;
Makino, H ;
Yamasaki, K ;
Azuma, J ;
Sawa, Y ;
Matsuda, H ;
Kaneda, Y ;
Ogihara, T .
HYPERTENSION, 2004, 44 (02) :203-209
[16]   MOLECULAR-CLONING AND EXPRESSION OF HUMAN HEPATOCYTE GROWTH-FACTOR [J].
NAKAMURA, T ;
NISHIZAWA, T ;
HAGIYA, M ;
SEKI, T ;
SHIMONISHI, M ;
SUGIMURA, A ;
TASHIRO, K ;
SHIMIZU, S .
NATURE, 1989, 342 (6248) :440-443
[17]   PARTIAL-PURIFICATION AND CHARACTERIZATION OF HEPATOCYTE GROWTH-FACTOR FROM SERUM OF HEPATECTOMIZED RATS [J].
NAKAMURA, T ;
NAWA, K ;
ICHIHARA, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 122 (03) :1450-1459
[18]   Hepatocyte growth factor may accelerate healing in chronic leg ulcers:: a pilot study [J].
Nayeri, F ;
Strömberg, T ;
Larsson, M ;
Brudin, L ;
Söderström, C ;
Forsberg, P .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2002, 13 (02) :81-86
[19]   Development of highly sensitive enzyme-linked immunosorbent assays for hepatocyte growth factor/scatter factor (HGF/SF): determination of HGF/SF in serum and urine from normal human subjects [J].
Ohnishi, T ;
Kakimoto, K ;
Hashida, S ;
Fujii, M ;
Hirono, S ;
Nishiyama, K ;
Amita, Y ;
Ishikawa, E ;
Tsubouchi, H ;
Daikuhara, Y .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 244 (1-2) :163-173
[20]   Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial [J].
Powell, RJ ;
Dormandy, J ;
Simons, M ;
Morishita, R ;
Annex, BH .
VASCULAR MEDICINE, 2004, 9 (03) :193-198